LENZ Therapeutics LENZ Stock Market Influencing Factors LENZ Therapeutics posts 171 EPS miss on wider quarterly loss GRC GormanRupp posts 282 percent EPS beat over analyst estimates for Q1 2026 shares climb 324 percent MaxCyte MXCT Stock ShortTerm Trend Technical Strength 20260427 How recession probability Materialise MTLS Slight Gain 20260427 HNNA Hennessy Advisors releases Q1 2026 earnings results shares dip 065 percent in todays trading session